Winton Group LTD Sutro Biopharma, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$16.88 - $22.38 $179,822 - $238,414	-10,653 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$18.03 - $23.82 $4,020 - $5,311	-223 Reduced 2.05%	10,653 $198,000
Q1 2021 Jul 21, 2021	BUY	$20.29 - $27.54 $220,674 - $299,525	10,876 New	10,876 $248,000
Q4 2020 Feb 12, 2021	SELL	$10.16 - $23.98 $135,930 - $320,828	-13,379 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$7.44 - $13.15 $99,539 - $175,933	13,379 New	13,379 $134,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.